The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3 SUPPL., 2005, Pages 1094-1099

  Thung, Stephen F ^a   Grobman, William A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cost effectiveness; Fetal and neonatal alloimmune thrombocytopenia

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

BRAIN HEMORRHAGE; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; FEMALE; FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; FETUS BLOOD SAMPLING; FETUS DISEASE; FETUS RISK; GESTATIONAL AGE; HEALTH CARE COST; HUMAN; IMMUNOTHERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEWBORN CARE; NEWBORN DISEASE; PERINATAL DEATH; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; SENSITIVITY ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

CORDOCENTESIS; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; FETAL DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; PLATELET COUNT; PREGNANCY; QUALITY-ADJUSTED LIFE YEARS; RETREATMENT; THROMBOCYTOPENIA; UNITED STATES;

EID: 24644496672     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.05.048     Document Type: Conference Paper

References (26)

1. J.B. Bussel, M.R. Zabusky, R.L. Berkowitz, and J.G. McFarland Fetal alloimmune thrombocytopenia N Engl J Med 337 1997 22 26
2. C. Mueller-Eckhardt, V. Kiefel, A. Grubert, H. Kroll, M. Weisheit, and S. Schmidt 348 cases of suspected neonatal alloimmune thrombocytopenia Lancet 1 1989 363 366
3. J.H. Herman, M.I. Jumbelic, R.J. Ancona, and T.S. Kickler In utero cerebral hemorrhage in alloimmune thrombocytopenia Am J Pediatr Hematol Oncol 8 1986 312 317
4. J.B. Bussel, R.L. Berkowitz, J.G. McFarland, L. Lynch, and U. Chitkara Antenatal treatment of neonatal alloimmune thrombocytopenia N Engl J Med 319 1988 1374 1378
5. L. Lynch, J.B. Bussel, J.G. McFarland, U. Chitkara, and R.L. Berkowitz Antenatal treatment of alloimmune thrombocytopenia Obstet Gynecol 80 1992 67 71
6. J.B. Bussel, R.L. Berkowitz, L. Lynch, M.L. Lesser, M.J. Paidas, and C.L. Huang Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin Am J Obstet Gynecol 174 1996 1414 1423
7. M.J. Paidas, R.L. Berkowitz, L. Lynch, C.J. Lockwood, R. Lapinski, and J.G. McFarland Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis Am J Obstet Gynecol 172 1995 475 479
8. T.G. Overton, K.R. Duncan, M. Jolly, E. Letsky, and N.M. Fisk Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome Am J Obstet Gynecol 186 2002 826 831
9. J.E. Birchall, M.F. Murphy, C. Kaplan, and H. Kroll European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia Br J Haematol 122 2003 275 288
10. C.M. Radder, A. Brand, and H.H. Kanhai A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia Am J Obstet Gynecol 185 2001 683 688
11. S. Gaddipati, R.L. Berkowitz, A.A. Lembet, R. Lapinski, J.G. McFarland, and J.B. Bussel Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility Am J Obstet Gynecol 185 2001 976 980
12. C.P. Weiner, and K. Okamura Diagnostic fetal blood sampling-technique related losses Fetal Diagn Ther 11 1996 169 175
13. L.M. Williamson, G. Hackett, J. Rennie, C.R. Palmer, C. Maciver, and R. Hadfield The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening Blood 92 1998 2280 2287
14. T. Ghi, G. Simonazzi, A. Perolo, L. Savelli, F. Sandri, and B. Bernardi Outcome of antenatally diagnosed intracranial hemorrhage: case series and review of the literature Ultrasound Obstet Gynecol 22 2003 121 130
15. P. Vergani, N. Strobelt, A. Locatelli, G. Paterlini, P. Tagliabue, and E. Parravicini Clinical significance of fetal intracranial hemorrhage Am J Obstet Gynecol 175 1996 536 543
16. W.C. Hanigan, F.C. Powell, T.C. Miller, and R.M. Wright Symptomatic intracranial hemorrhage in full-term infants Childs Nerv Syst 11 1995 698 707
17. J.A. Martin, B.E. Hamilton, S.J. Ventura, F. Menacker, M.M. Park, and P.D. Sutton Births: final data for 2001 Natl Vital Stat Rep 51 2002 1 102
18. T.O. Tengs, and M.A. Wallace One thousand health-related quality-of-life estimates Medical Care 38 2000 583 637
19. D.L. Hoyert, H.C. Kung, and B.L. Smith Deaths: preliminary data for 2003 Natl Vital Stat Rep 53 2003 1 47
20. J.R. Adams, D.P. Nathan, and C.L. Bennett Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy Blood Rev 16 2002 65 67
21. 2003 Red Book: Pharmacy's fundamental reference 2003 Medical Economics Data Productions Co Montvale, NJ
22. Medical Fees in the United States: nationwide charges for medicine, surgery, laboratory, radiology 2004 Practice Management Information Co Los Angeles, CA
23. W.A. Grobman, A.M. Peaceman, and M.L. Socol Cost effectiveness of elective cesarean delivery after one prior low transverse cesarean Obstet Gynecol 95 2000 745 751
24. A.G. Randolph, R.M. Hartshorn, and A.E. Washington Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis Obstet Gynecol 88 1996 603 610
25. N.J. Waitzman, P.S. Romano, and R.M. Scheffler Estimates of the economic costs of birth defects Inquiry 33 1994 188 205
26. A.B. Caughey, M. Kuppermann, M.E. Norton, and A.E. Washington Nuchal translucency and first trimester biochemical markers for Down syndrome screening: a cost-effectiveness analysis Am J Obstet Gynecol 187 2002 1239 1245